Precision ADM Inc reported on Thursday the receipt of the ISO 13485:2016 Quality Management System certification for its first Canadian metal Additive and Subtractive manufacturing services company.
This ISO 13485:2016 industry standard reportedly represents the comprehensive set of requirements for the design and manufacture of medical devices.
Achieving ISO 13485 Registration and Certification allows the company to manufacture medical devices, including Orthopaedic Implants, using the latest digital manufacturing technologies that can lower production costs by reducing waste and decreasing time to market by simplifying - or eliminating - tooling and equipment.
The Additive Manufacturing makes it possible to produce custom, patient-specific designs and devices with complex geometries, with potential lower cost than traditional manufacturing methods. The company is currently targeting additively manufactured medical devices produced in Titanium, Cobalt-Chrome and stainless-steel alloys.
Headquartered in Winnipeg, Manitoba, Canada, Precision ADM Inc is an engineering and manufacturing solutions provider that uses Additive Manufacturing, also known as 3D Printing, as a core technology, complimented by multi-axis machining to manufacture high value components and devices for the medical and industrial sectors.
Abingdon Health supports UK launch of LVOne stroke triage test
Fesarius Therapeutics reports publication of DermiSphere hDRT data
Shield Therapeutics announces Phase II trial initiation of ACCRUFeR in Japan for PAH
Johnson & Johnson secures EU approval for ETHICON 4000 surgical stapler
Implantica publishes large-scale RefluxStop study showing strong long-term safety outcomes
D2 Solutions acquires ProModRx
Orthocell gains approval for Remplir across US defence and veterans hospital networks
QT Imaging Debuts QT Imaging-Olea Viewer for integrated multimodality breast imaging
MedPal AI launches integrated health OS platform to drive scalable digital healthcare
CenExel appoints Dr. Sy Pretorius as CEO
QT Imaging launches next-generation breast imaging reconstruction software
Tempus and Medtronic report positive ALERT trial results for AI-driven cardiac care
US FDA approves i-Lumen Scientific's i-SIGHT2 clinical study for dry AMD